NDC Compounded Drug 63037-162-25 Lidocaine Hydrochloride Anhydrous

Injection Infiltration

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Lidocaine Hcl
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 63037-162
NDC Package Code 63037-162-25
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 63037016225
Package Description 5 mL in 1 SYRINGE, PLASTIC
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Lidocaine Hcl
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Lidocaine Hcl 1%
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Lidocaine Hydrochloride Anhydrous
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Infiltration - Administration that results in substances passing into tissue spaces or into cells.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 63037
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Hikma Injectables Usa Inc.
Substance Name Lidocaine Hydrochloride Anhydrous
Active Ingredients Information 50 mg/5 mL
Reporting Period 2023-2

NDC Crossover Products Matching Lidocaine Hydrochloride Anhydrous

NDC crossover of Lidocaine Hcl with NDC 63037-162 a human compounded drug with other similar products matching the same substance name (Lidocaine Hydrochloride Anhydrous) and the same administration route (infiltration) or dosage form (injection).

Frequently Asked Questions

What is the NDC number assigned to Lidocaine Hcl?

Lidocaine Hcl was assigned by its manufacturer with NDC product code 63037-162. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Lidocaine Hcl?

The NDC package code 63037-162-25 was assigned to a 5 mL in 1 SYRINGE, PLASTIC of lidocaine hydrochloride anhydrous administered infiltration via injection.

Who manufactures this product?

Lidocaine Hcl is manufactured by an outsourced facility and labeled by Hikma Injectables Usa Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 5 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma and Hikma Injectables USA Inc. with NDC product codes 26436-5480-1, 26436-5480-1, 26436-5480-1, 63037-164-25 and 63037-164-25.